It has been suggested that MHO individuals are simply on a different trajectory to more overt metabolic dysfunction but there is also the possibility that genetic background, body fat distribution, or diet and exercise history might influence the relationship between obesity and insulin action (Vilela et al., 2021; Gómez-Zorita et al., 2021). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.